Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Possibly Marketed Outside US

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Not Provided

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2005

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

sunburn

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Inactive ingredient

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

1

DAILYMED

1

ECHA (EC/EINECS)

1

EPA CompTox

1

FDA UNII

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

DICAPRYLYL ETHER

77JZM5516Z

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2005

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1